Tag #Genetic Disorder

Showing 1 to 6 of 6 results

bbc.com

🌐 85% Global Worthiness

Sep 22, 01:18

Rare Genetic Disorder DRPLA Cluster in South Wales

A cluster of people in south Wales are affected by Dentatorubral-pallidoluysian atrophy (DRPLA), a rare, inherited neurological disorder with no known cure, impacting families and raising concerns about early diagnosis and treatment.

Rare Genetic Disorder DRPLA Cluster in South Wales

A cluster of people in south Wales are affected by Dentatorubral-pallidoluysian atrophy (DRPLA), a rare, inherited neurological disorder with no known cure, impacting families and raising concerns about early diagnosis and treatment.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of the DRPLA cluster on families in South Wales?

The primary impact is the severe, progressive neurological decline affecting individuals, often starting in their 20s and 30s, leading to loss of mobility, speech, and cognitive function. Families face significant emotional distress, substantial financial burdens from private testing and caregiving, and the profound uncertainty of a currently incurable disease.

es.euronews.com

🌐 85% Global Worthiness

May 21, 10:11

CRISPR Gene Editing Shows Promise in Treating Rare Infant Disorder

A six-month-old American baby with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom CRISPR gene-editing therapy resulting in a reduction of medication dependency and improved health.

CRISPR Gene Editing Shows Promise in Treating Rare Infant Disorder

A six-month-old American baby with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom CRISPR gene-editing therapy resulting in a reduction of medication dependency and improved health.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate health impacts and long-term implications of using CRISPR gene editing to treat severe CPS1 deficiency in infants?

An American baby, KJ, became one of the first people treated with a custom CRISPR gene-editing therapy for severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder affecting about one in a million babies. This condition causes a buildup of ammonia in the blood, potentially leading to coma and death; standard treatment involves a protein-restricted diet and may necessitate a liver transplant. CRISPR therapy targeted a faulty gene in KJ's liver, correcting the enzyme and reducing reliance on medication.

npr.org

🌐 95% Global Worthiness

May 15, 22:14

Gene Editing Successfully Treats Baby's Life-Threatening Genetic Disorder

Doctors successfully used a personalized gene-editing therapy to treat baby KJ Muldoon's life-threatening genetic disorder, carbamoyl phosphate synthetase 1 (CPS1), showing potential for treating numerous rare diseases previously untreatable.

Gene Editing Successfully Treats Baby's Life-Threatening Genetic Disorder

Doctors successfully used a personalized gene-editing therapy to treat baby KJ Muldoon's life-threatening genetic disorder, carbamoyl phosphate synthetase 1 (CPS1), showing potential for treating numerous rare diseases previously untreatable.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this case demonstrate the potential of personalized medicine in addressing rare diseases?

This case demonstrates the potential of gene editing to treat rare genetic disorders previously untreatable. The successful application of a bespoke gene-editing therapy to KJ Muldoon's CPS1 highlights the feasibility of personalized treatments for conditions with limited therapeutic options. The progress could accelerate the development of similar therapies for other rare diseases, opening new avenues for treatment.

euronews.com

🌐 90% Global Worthiness

Jul 30, 19:17

Gene Therapy Restores Sight in Usher Syndrome Patient

A 38-year-old Italian man with Usher syndrome type 1b regained his sight after an experimental gene therapy at the University of Campania in July 2024; seven more patients underwent the procedure, showing promising results and paving the way for broader application.

Gene Therapy Restores Sight in Usher Syndrome Patient

A 38-year-old Italian man with Usher syndrome type 1b regained his sight after an experimental gene therapy at the University of Campania in July 2024; seven more patients underwent the procedure, showing promising results and paving the way for broader application.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the global significance of this successful gene therapy for Usher syndrome type 1b?

In a groundbreaking medical achievement, a 38-year-old Italian man with Usher syndrome type 1b, a genetic disorder causing blindness, has fully recovered his sight after an experimental gene therapy. The therapy, involving injecting two viral vectors carrying the missing gene, was performed at the University of Campania. The patient, who previously had severely limited vision, now has restored near and far vision, even at night.

npr.org

🌐 95% Global Worthiness

May 16, 10:13

Gene Editing Successfully Treats Baby's Life-Threatening Disorder

Doctors successfully treated a baby born with a life-threatening urea cycle disorder using a custom gene-editing therapy in Philadelphia, marking a major breakthrough in personalized medicine; the therapy appears to be working, allowing the baby to eat more protein, gain weight, and reach developmen...

Gene Editing Successfully Treats Baby's Life-Threatening Disorder

Doctors successfully treated a baby born with a life-threatening urea cycle disorder using a custom gene-editing therapy in Philadelphia, marking a major breakthrough in personalized medicine; the therapy appears to be working, allowing the baby to eat more protein, gain weight, and reach developmen...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did the research team overcome the challenges posed by the rarity of the disease and the need for rapid treatment?

KJ's treatment highlights the potential of gene editing to address rare genetic diseases previously untreatable. The researchers overcame challenges in creating rapid, patient-specific therapies, demonstrating the feasibility of this approach for other similar conditions. The success offers hope for millions of babies suffering from various rare genetic disorders.

theguardian.com

🌐 90% Global Worthiness

May 15, 22:14

Gene Editing Successfully Treats Baby with Rare Genetic Disorder

US doctors successfully used a customized gene-editing therapy to treat a baby, KJ, with severe CPS1 deficiency, a rare genetic disorder, showing early signs of success and highlighting the potential of gene editing for treating various genetic diseases.

Gene Editing Successfully Treats Baby with Rare Genetic Disorder

US doctors successfully used a customized gene-editing therapy to treat a baby, KJ, with severe CPS1 deficiency, a rare genetic disorder, showing early signs of success and highlighting the potential of gene editing for treating various genetic diseases.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of successfully treating a baby with a customized gene-editing therapy for a severe genetic disorder?

Doctors successfully treated a baby, KJ, with a customized gene-editing therapy for severe CPS1 deficiency, a rare genetic disorder affecting 1 in 1.3 million. The therapy, involving base editing to correct faulty DNA, was administered in three doses between February and April. KJ is thriving but requires lifelong monitoring.

Showing 1 to 6 of 6 results